Inventor
FA-XIANG DING
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%
C07DHeterocyclic compounds15%
C07KPeptides15%
C12NMicroorganisms or enzymes6%
C12YEnzymes6%
C07CAcyclic or carbocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
Y02ATechnologies for adaptation to climate change3%
PatentTitleYear
12,448,384Diacylglyceride O-acyltransferase 2 inhibitors202512,209,145PCSK9 antagonist compounds202512,178,842PCSK9 antagonist compounds202411,738,010Oxazolidinones as TarO inhibitors202311,484,565PCSK9 antagonist compounds202211,427,616PCSK9 antagonist compounds202211,306,125PCSK9 antagonists bicyclo-compounds202211,230,543Biaryl monobactam compounds and methods of use thereof for the treatment of bacterial infections202211,141,410Oxazolidinones as taro inhibitors2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2023Patents assigned to MERCK SHARP & DOHME (4)· patent assignee history
2021–2025Based in US· patent location history
2022–2025Patents assigned to MERCK SHARP & DOHME LLC (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME LLC | 5 | 2022–2025 |
| MERCK SHARP & DOHME | 4 | 2021–2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2021–2025 |